- Home
- AMPX vs KOD Comparison
AMPX vs KOD Comparison
Compare AMPX & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMPX | KOD |
|---|---|---|
| Founded | 2008 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 795.5M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | AMPX | KOD |
|---|---|---|
| Price | $8.52 | $30.90 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $13.33 | ★ $22.67 |
| AVG Volume (30 Days) | ★ 5.3M | 891.7K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $58,408,000.00 | N/A |
| Revenue This Year | $205.06 | N/A |
| Revenue Next Year | $127.60 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 234.14 | N/A |
| 52 Week Low | $1.70 | $1.92 |
| 52 Week High | $16.03 | $29.49 |
Technical Indicators
Market Signals| Indicator | AMPX | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 35.11 | 71.82 |
| Support Level | $8.77 | $25.44 |
| Resistance Level | $11.58 | $29.49 |
| Average True Range (ATR) | 0.76 | 2.17 |
| MACD | -0.23 | 0.36 |
| Stochastic Oscillator | 3.35 | 98.14 |
Price Performance
Historical ComparisonAbout AMPX Amprius Technologies Inc.
Amprius Technologies Inc is engaged in the production of silicon anodes for high-energy-density lithium-ion batteries. The company develops, manufactures and markets lithium-ion batteries for mobility applications, including the aviation, electric vehicle (EV) and light electric vehicle (LEV) industries. The company's batteries are used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.